Sign In
Buy BIO
$301.70
-0.200 (-0.0662%)
At Close: Jul 21, 2026
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
12:04pm, Tuesday, 11'th Oct 2022
A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day. The post Why Bio-Rad Laboratories' Rumored $10 Billion Qiage
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
12:56am, Tuesday, 11'th Oct 2022 MarketWatch
The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more — and there may not be one.
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
08:56pm, Monday, 10'th Oct 2022
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
Bio-Rad Laboratories in Talks to Combine With Qiagen
02:03pm, Monday, 10'th Oct 2022
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?
01:57pm, Monday, 10'th Oct 2022 Zacks Investment Research
Walgreens (WBA) is expected to have registered growth in Q4 in its U.S. retail pharmacy business, banking on demand for vaccinations and tests amid the ongoing series of contagious virus spread.
Reasons to Retain Veeva Systems (VEEV) Stock in Your Portfolio
05:26pm, Friday, 07'th Oct 2022 Zacks Investment Research
Veeva Systems' (VEEV) slew of strategic deals raises optimism about the stock.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now
05:08pm, Friday, 07'th Oct 2022 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Here's Why You Should Retain Inari Medical (NARI) Stock Now
04:44pm, Thursday, 06'th Oct 2022 Zacks Investment Research
Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, dependency on the wide adoption of products is a woe.
BD's (BDX) Latest Monkeypox PCR Assay Commercially Available
02:00pm, Monday, 03'rd Oct 2022 Zacks Investment Research
BD's (BDX) new molecular RUO PCR assay is expected to aid in better managing the ongoing global monkeypox outbreak.
The S&P 500 sank 5% in a very bad week for stocks. These 20 lost as much as 24%.
10:12am, Monday, 19'th Sep 2022 MarketWatch
A profit warning from FedEx, an expensive acquisition for Adobe and fear of the Federal Reserve all weighed on the stock market.
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
03:37pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Here's Why You Should Retain Change Healthcare (CHNG) Stock
03:12pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.
Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates
02:59pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.
Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates
02:45pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Despite a decline in the bottom line, Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.
Here's Why You Should Retain AngioDynamics (ANGO) Stock Now
03:16pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
AngioDynamics (ANGO) continues to benefit from strength in segments but forex remains a woe.
